Revolo completes patient enrollment in phase 2 trial of ‘1104 in eosinophilic esophagitis: New Orleans Wednesday, September 14, 2022, 14:30 Hrs [IST] Revolo Biotherapeutics (Rev ...
Frequent dry eyes may signal more than simple irritation and could be an early warning sign of an autoimmune disease. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results